A Republican bill with 3 Republican cosponsors · See all 3 cosponsors
Last activity — Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
In committee
Introduced and handed to a committee in the chamber it started in.
The committee holds it, and most bills are never heard from again. A hearing or a committee vote would be news; silence is the usual outcome, and it kills the bill without anyone voting against it.
Its path through Congress
- Introduced
- In Committee
What this bill would do
This bill, known as the "ISLET Act," aims to regulate human cadaveric islets for transplantation as organs. It proposes amending the Public Health Service Act to include "human cadaveric islets" alongside the pancreas. The bill clarifies that these islets are not considered drugs, biological products, or human cells, tissues, or cellular or tissue-based products. Additionally, it directs the Secretary of Health and Human Services to update specific regulations within one year. Finally, the Secretary must report to Congress on the progress of these updates within six months.
Yes· 3 of 4
- Scored +5
Does this make health care easier to get in general?
The bill establishes a regulatory framework for human cadaveric islet transplantation, which can increase access to this life-saving treatment.
- Scored +4
Would people with disabilities be better off under this?
The regulation of islet transplants may provide medical benefits to individuals living with endocrine-related disabilities like diabetes.
- Scored +3
Does this put more money into medical research?
By clarifying the regulatory status of islets, the bill facilitates the clinical application and potential research into islet transplantation.
The opposite
No question was scored the opposite.
Who it would affect, and how
Potential Positive Impacts for People
-
Updated Regulations: The Secretary of Health and Human Services is required to update regulations related to the Public Health Service Act and the Federal Food, Drug, and Cosmetic Act to include human cadaveric islets (Section 2(c)(1)). This ensures that the transplantation of these islets is governed by updated regulatory frameworks.
-
Congressional Oversight: The Secretary is required to provide a report to Congress regarding the progress of updating regulations within six months of the act's enactment (Section 2(c)(2)). This provides a mechanism for transparency and accountability in the regulatory process.
Potential Negative Impacts for People
- No specific negative impacts or burdens are explicitly mentioned in the text of the bill.
Groups and Interests Ranking
Every group the model scored this bill for, from -10 to +10. Tap or hover a score for the reason it gave.
- Healthcare
- Does this make health care easier to get in general? — The bill establishes a regulatory framework for human cadaveric islet transplantation, which can increase access to this life-saving treatment. Does this put more money into medical research? — By clarifying the regulatory status of islets, the bill facilitates the clinical application and potential research into islet transplantation.
- Demographic And Interest Groups
- Would people with disabilities be better off under this? — The regulation of islet transplants may provide medical benefits to individuals living with endocrine-related disabilities like diabetes.
- Governance And Ideology
- Does this make what the government does easier for the public to see? — The bill requires the Secretary of Health and Human Services to report progress to Congress, enhancing oversight and transparency.
- 5/11/2026
- 1 Cosponsor added.
- 4/27/2026
- 1 Cosponsor added.
- 11/5/2025
- Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
- 1 Cosponsor added.
- Introduced in Senate
One bill Congress.gov lists as related to this one — companions in the other chamber, earlier versions, and bills this one absorbed or was folded into.
Ted BuddRepublican · North Carolina
David McCormickRepublican · Pennsylvania
Tommy TubervilleRepublican · Alabama